LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Large Joints and Extremities/Outcome Data for Arthroscopic Hip Labral Augmentation
Large Joints and Extremities

Outcome Data for Arthroscopic Hip Labral Augmentation

March 15, 2022 2 min read Premium comments

Advertisement

Secondary#hiparthroscopy#hiplabralaugmentation

A new study provides updated outcome data for arthroscopic hip labral augmentation as a treatment for labral insufficiency after previous hip arthroscopy.

In the study, “Midterm Outcomes After Hip Labral Augmentation in Revision Hip Arthroscopy,” published on March 2, 2022, in The American Journal of Sports Medicine, the researchers evaluated the midterm outcomes of arthroscopic hip labral augmentation for labral insufficiency after previous hip arthroscopy.

“Labral augmentation has emerged as an essential procedure to address a deficient or irreparable labrum while preserving native labral tissue and restoring the hip suction seal mechanism,” the researchers wrote.

Seventy-seven patients who underwent hip labral augmentation between January 2011 and January 2017 were included in the study. Each patient has a minimum of 3 years of follow-up.

The researchers compared pre- and postoperative patient-reported outcome scores including the 12-Item Short Form Health Survey physical and mental component summaries, Western Ontario and McMaster Universities Osteoarthritis Index, modified Harris Hip Score and Hip Outcome Score (Activities of Daily Living and Sport). They also evaluated postoperative Tegner Activity Scale and patient satisfaction scores.

The average age of the patients was 32.8 ± 11 years. The survivorship or absence of conversion to total hip arthroplasty at 3 years and 5 years was 93% at both time points. Mean survival time was 8.5 years (95% CI, 8.0-8.9).

Eleven of the patients required revision arthroscopic surgery for continued pain. Revisions occurred at a mean of 2.6 ± 1.4 years after augmentation. The mean follow-up was 5.2 ± 1.2 years (range, 3-9 years).

For the patients who didn’t require additional surgery, all patient-reported outcomes measures were significantly improved including a 20-point increase in Hip Outcome Scores-Activities of Daily Living and modified Harris Hip Score.

Advertisement

The median postoperative Tegner score was 4 (range, 1-10). The median postoperative Tegner score was 4 (range, 1-10). The median postoperative patient satisfaction score was 9 out of 10 (range, 1-10).

“Arthroscopic hip labral augmentation is a successful treatment option for patients with labral insufficiency after previous hip arthroscopy, demonstrating improved patient-reported outcomes and survivorship of 93% at 3 years and 5 years. This technique provides a valuable labral preservation option when addressing hip labral pathology when viable native labral tissue remains,” the researchers wrote.

The study authors included Rui W. Soares, M.D., Joseph J. Ruzbarsky, M.D., Justin W. Arner, M.D., Spencer M. Comfort, Karen K. Briggs, M.P.H., M.B.A, and Marc. J. Philippon, M.D., all of the Steadman Philippon Research Institute in Vail, Colorado.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy